Second Edition: Pharmacotherapy during Pregnancy, Childbirth and Lactation
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Global Health".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 7782
Interests: perinatal pharmacology; neonatal clinical pharmacology; PBPK in special populations; newborn; infant; lactation
Special Issues, Collections and Topics in MDPI journals
2. Teratology Information Service, Netherlands Pharmacovigilance Centre Lareb, 5237 MH Hertogenbosch, The Netherlands
Interests: perinatal pharmacoepidemiology; drug safety; pharmacotherapy; drug information; pharmaceutical care; teratology; breastfeeding
Pharmacotherapy is a very powerful tool to improve the medical outcome for pregnant women and their newborns. As little as 5% of available drugs have been properly monitored, tested, and labeled for use in pregnancy and lactation. Pregnant or lactating women are usually excluded from clinical trials, while product development for diseases specific to pregnancy or perinatal indications is very limited. However, in real life, pregnant women get ill, and ill women get pregnant. Pregnant or lactating women and their caregivers are left in the dark about risks they cannot oversee, and they need to take responsibility for this uncertainty.
This Special Issue on perinatal clinical pharmacology aims to focus on various methods that can be applied and tailored to pregnancy and lactation, including but not limited to pharmacokinetic modeling, pharmaco-epidemiology, in vitro models (such as placental transfer), lactation and pharmacovigilance. Papers on pharmacotherapy on diseases related to pregnancy (preterm labor, pre-eclampsia, fetal anomalies, postpartum hemorrhage) and diseases that occur during pregnancy (depression, oncological diseases, peri-operative care, infectious diseases) are very welcome. Papers on pharmacovigilance or policy strategies specific to pregnancy or lactation are hereby also very welcome.
Prof. Dr. Karel Allegaert
Dr. Michael Ceulemans
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug safety
- drug information